Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 4.27 is 23% below its 5-year average of 5.55, near the low end of its 5-year range (0.40–14.08).
As of the fiscal period ended Tuesday, June 30, 2026. 199.48% above its 12-month average of 1.43.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 4.27.
QUICK RATIO (ACID-TEST)
4.27
QUICK RATIO (ACID-TEST) AVG TTM
1.43
QUICK RATIO (ACID-TEST) AVG 3Y
2.81
QUICK RATIO (ACID-TEST) AVG 5Y
5.55
QUICK RATIO (ACID-TEST) AVG 10Y
5.16
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+199.48%
CURRENT VS 3Y AVG
+51.81%
CURRENT VS 5Y AVG
-23.12%
CURRENT VS 10Y AVG
-17.27%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+27.45%
vs the sector median at left
Rein Therapeutics Inc.
Market Cap
$22.92M
Quick Ratio (Acid-Test)
4.27
TTM Avg
1.43
3Y Avg
2.81
5Y Avg
5.55
Market Cap
$23.26M
Quick Ratio (Acid-Test)
3.22
TTM Avg
2.47
3Y Avg
1.96
5Y Avg
1.72
Market Cap
$22.50M
Quick Ratio (Acid-Test)
7.01
TTM Avg
3.03
3Y Avg
5.29
5Y Avg
15.48
Market Cap
$22.25M
Quick Ratio (Acid-Test)
3.25
TTM Avg
7.36
3Y Avg
6.36
5Y Avg
5.93
Market Cap
$23.92M
Quick Ratio (Acid-Test)
2.59
TTM Avg
2.35
3Y Avg
1.92
5Y Avg
2.36
Market Cap
$22.00M
Quick Ratio (Acid-Test)
1.00
TTM Avg
1.04
3Y Avg
0.94
5Y Avg
0.89
Market Cap
$24.59M
Quick Ratio (Acid-Test)
5.69
TTM Avg
10.26
3Y Avg
14.54
5Y Avg
17.67
Market Cap
$24.91M
Quick Ratio (Acid-Test)
0.07
TTM Avg
0.37
3Y Avg
0.39
5Y Avg
0.82
Market Cap
$25.30M
Quick Ratio (Acid-Test)
3.52
TTM Avg
5.18
3Y Avg
5.31
5Y Avg
5.55
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rein Therapeutics Inc. (RNTX) | $22.92M | 4.27 | 1.43 | 2.81 | 5.55 |
| TherapeuticsMD, Inc. (TXMD)vs › | $23.26M | 3.22 | 2.47 | 1.96 | 1.72 |
| LeonaBio, Inc. (LONA)vs › | $22.50M | 7.01 | 3.03 | 5.29 | 15.48 |
| Modular Medical, Inc. (MODD)vs › | $22.25M | 3.25 | 7.36 | 6.36 | 5.93 |
| Kyntra Bio, Inc. (KYNB)vs › | $23.92M | 2.59 | 2.35 | 1.92 | 2.36 |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.00M | 1.00 | 1.04 | 0.94 | 0.89 |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.59M | 5.69 | 10.26 | 14.54 | 17.67 |
| ABVC BioPharma, Inc. (ABVC)vs › | $24.91M | 0.07 | 0.37 | 0.39 | 0.82 |
| InspireMD, Inc. (NSPR)vs › | $25.30M | 3.52 | 5.18 | 5.31 | 5.55 |
| NextCure, Inc. (NXTC)vs › | $20.29M | 3.47 | 5.82 | 11.52 | 18.07 |
Quick Ratio
4.27
Excludes inventory
Current Ratio
4.27
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 4.27 |
| 2026-03-31 | 0.40 |
| 2025-12-31 | 0.70 |
| 2025-09-30 | 0.90 |
| 2025-06-30 | 0.86 |
| 2025-03-31 | 1.39 |
| 2024-12-31 | 2.38 |
| 2024-09-30 | 3.30 |
| 2024-06-30 | 4.69 |
| 2024-03-31 | 2.82 |
| 2023-12-31 | 4.17 |
| 2023-09-30 | 7.88 |
| 2023-06-30 | 11.66 |
| 2023-03-31 | 5.93 |
| 2022-12-31 | 6.46 |
| 2022-09-30 | 5.96 |
| 2022-06-30 | 6.51 |
| 2022-03-31 | 9.65 |
| 2021-12-31 | 10.69 |
| 2021-09-30 | 11.93 |
| 2021-06-30 | 14.08 |
| 2021-03-31 | 20.93 |
| 2020-12-31 | 4.12 |
| 2020-09-30 | 3.04 |
| 2020-06-30 | 3.99 |
| 2020-03-31 | 2.23 |
| 2019-12-31 | 3.35 |
| 2019-09-30 | 4.12 |
| 2019-06-30 | 6.04 |
| 2019-03-31 | 3.11 |
| 2018-12-31 | 4.05 |
| 2018-09-30 | 4.23 |
| 2018-06-30 | 5.85 |
| 2018-03-31 | 9.15 |
| 2017-12-31 | 10.60 |
| 2017-09-30 | 11.57 |
| 2017-06-30 | 2.19 |
| 2017-03-31 | 5.57 |
| 2016-12-31 | 5.18 |
